skip to main menu skip to content skip to footer

Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

GT Medical Technologies - GTM-101 - (STaRT Registry)

Study Phase: Observational - Registry

Condition(s): Intracranial bran neoplasms
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms

ClinicalTrials.gov NCT ID: NCT04427384

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_amy-grossman

Amy Grossman, RN

Primary Contact - Study Coordinator


484-658-1788
amy.grossman@sluhn.org

profile_william-smith

William H. Smith, MD

Physician - Principal Investigator


NRG - NRG-BN013

Study Phase: Phase III - Radiation Therapy

Condition(s): Brain metastases from non-small cell lung cancer, melanoma, breast, renal or GI cancers
Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) For Intact Brain Metastases

ClinicalTrials.gov NCT ID: NCT06500455

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_amy-grossman

Amy Grossman, RN

Primary Contact - Study Coordinator


484-658-1788
amy.grossman@sluhn.org

profile_david-andolino

David L. Andolino, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.